Increasing evidence regarding free radical-generating agents and inflammato
ry processes suggests that accumulation of reactive oxygen species can caus
e hepatotoxicity. A short-chain analog of lipid hydroperoxide, t-butyl hydr
operoxide (t-BHP), can be metabolized to free radical intermediates by cyto
chrome P-450 in hepatocytes, which in turn can initiate lipid peroxidation,
affect cell integrity and result in cell injury. In this study, we used t-
BHP Co induce hepatotoxicity in vitro and in vivo and determined the antiox
idative bioactivity of esculetin, a coumarin compound. Our investigations s
howed that pretreatment with esculetin (5-20 mug/ml) significantly decrease
d the leakage of lactate dehydrogenase (LDH) and alanine transaminase (ALT)
, and also decreased the formation of malondialdehyde (MDA) in primary cult
ured rat hepatocytes induced by a 30-min treatment with t-BHP. An in vivo s
tudy in rats showed that pretreatment with esculetin (i.p.) at concentratio
ns of 0.5 and 5 mg/kg for 5 days before a single i.p. dose of t-BHP (0.1 mm
ol/kg) significantly lowered the serum levels of the hepatic enzyme markers
(ALT and AST) and reduced oxidative stress in the liver. Histopathological
evaluation of the rat livers revealed that esculetin reduced the incidence
of liver lesions induced by t-BHP, including hepatocyte swelling, leukocyt
e infiltration, and necrosis. Based on the results described above, we spec
ulate that esculetin may play a chemopreventive role via reducing oxidative
stress in living systems.